Cofoe Medical Technology Co.,Ltd. (SHE:301087)
China · Delayed Price · Currency is CNY 52.77
+1.07 (2.07%)
At close: Sep 11, 2026
Cofoe Medical Technology Revenue
Cofoe Medical Technology had revenue of 1.06B CNY in the quarter ending June 30, 2026, with 39.78% growth. This brings the company's revenue in the last twelve months to 3.96B, up 35.74% year-over-year. In the year 2025, Cofoe Medical Technology had annual revenue of 3.39B with 13.56% growth.
Revenue (ttm)
3.96B
Revenue Growth
+35.74%
P/S Ratio
2.92
Revenue / Employee
780.08K
Employees
5,081
Market Cap
11.55B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.39B | 404.57M | 13.56% |
| Dec 31, 2024 | 2.98B | 129.24M | 4.53% |
| Dec 31, 2023 | 2.85B | -123.26M | -4.14% |
| Jan 1, 2023 | 2.98B | 701.33M | 30.82% |
| Jan 1, 2022 | 2.28B | -99.63M | -4.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shandong Weigao Blood Purification Products | 3.76B |
| Double Medical Technology | 2.73B |
| Qingdao Haier Biomedical Co.,Ltd | 2.43B |
| SonoScape Medical | 2.40B |
| Jafron Biomedical | 1.91B |
| MeHow Innovative | 1.71B |
| Shandong Weigao Orthopaedic Device | 1.49B |
| Shanghai MicroPort Endovascular MedTech | 1.43B |